Related Experiment Video
Updated: Sep 29, 2025
07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.8K
Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort
María José Farfán Bajaña1, Jorge Moncayo-Rizzo1, Geovanny Alvarado-Villa1
1Department of Health Sciences, Universidad de Especialidades Espíritu Santo, Guayaquil 090101, Ecuador.
Medicina (Kaunas, Lithuania)
|March 26, 2022
Summary
Shared decision-making (SDM) in type 2 diabetes patients unexpectedly correlated with higher HbA1c levels in men. Further research is needed to understand this association in poorly controlled diabetes.
Area of Science:
- Endocrinology
- Public Health
- Patient-Centered Care
Background:
- Diabetes mellitus impacts over 422 million globally, with type 2 comprising 90%.
- Shared decision-making (SDM) empowers patients in managing their health.
- SDM is hypothesized to improve treatment adherence and lower HbA1c in diabetes patients.
Purpose of the Study:
- To identify predictors of HbA1c change in diabetes patients.
- To investigate the relationship between SDM and glycemic control.
Main Methods:
- A cohort of 76 endocrinology outpatients was studied.
- Data included demographics, BMI, SDM levels (SDMQ-9), and HbA1c.
- HbA1c was measured at baseline and three months later.
Main Results:
- SDM level significantly predicted HbA1c change in men.
- Higher SDM levels were unexpectedly associated with an increase, not a decrease, in HbA1c.
Conclusions:
- Elevated perceived SDM may correlate with poorer diabetic control, contrary to existing literature.
- Findings are not generalizable due to sample size and population specificity.
- Further investigation is required, particularly in patients with poorly controlled diabetes.
